Abstract Background Colonoscopy is essential in managing inflammatory bowel disease (IBD), facilitating disease activity assessment, mucosal healing monitoring, and colorectal cancer prevention. However, its invasive nature and associated discomfort often compromise patient satisfaction. This study evaluated patient satisfaction with colonoscopy and its determinants, including perceived stress, disease activity, procedural characteristics, and physician expertise. Methods This multicentric cross-sectional study was conducted between December 2023 and September 2024 at three endoscopy centres: Fondazione Policlinico Gemelli IRCCS, Azienda Sanitaria Universitaria Friuli Centrale and La Maddalena Cancer Center. Patients with IBD were consecutively recruited during routine colonoscopy appointments. Patient satisfaction was assessed using the Endoscopy Customer Satisfaction Questionnaire (ECSQ), and perceived stress was measured using the Perceived Stress Scale (PSS-10). Additional demographic and clinical data, including age, gender, prior colonoscopy experience, and disease activity, were collected via pre- and post-procedure questionnaires. Statistical analyses included linear regression to identify satisfaction determinants and Kruskal-Wallis tests to evaluate differences among patient subgroups. Results A total of 444 IBD patients were included (54% male; median age 45 years, interquartile range 38–53). Most patients (60%) had prior colonoscopy experience, and 70% were in clinical remission during the procedure. Average satisfaction measures with ECSQ scores indicated a moderate level. Higher satisfaction was associated with remission status (β = 1.705, p = 0.021), prior colonoscopy experience (β = 0.459, p = 0.041), and physician expertise (β = 2.111, p = 0.013). Severe disease activity negatively impacted satisfaction (β = −3.872, p < 0.001). Conclusion Improving patient satisfaction requires targeted strategies addressing disease activity, procedural experience, and stress management. Tailored interventions for specific patient subgroups could enhance adherence to colonoscopy surveillance, improve disease outcomes, and reduce cancer risk in IBD populations.
Read full abstract